About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01293565

Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A

The overall purpose of this study is to learn more about Hypohidrotic Ectodermal Dysplasia (HED) and to help in identifying treatment opportunities. Several evaluations will be conducted in this study...

Lead sponsor: Edimer Pharmaceuticals•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Edimer Pharmaceuticals

Age

14 - 29 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•1. Males age 14-29 years with clinical diagnosis of HED
•2. No scalp shaving in the 6 months prior to enrollment
•3. No current medical therapy for hair loss
•4. Written informed consent for study and genotyping (or signed medical release of previous genetic test results)

Exclusion Criteria

•1. Medically significant condition as determined by the PI
•2. Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists (e.g. Urecholine, Salagen, Pilocar, Provocholine)
•3. Presence of cardiac pacemaker

Related studies

Active Not Recruiting

Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

NCT07096206 · X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences

NCT04741412 · Hypohidrotic Ectodermal Dysplasia

Phenotypic Properties in Individuals Affected With XLHED

NCT01871714 · X Linked Hypohidrotic Ectodermal Dysplasia

Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation

NCT01386775 · Hypohidrotic Ectodermal Dysplasia

Sweat Duct Imaging in Mother/Newborn Dyads

NCT01342133 · X-Linked Hypohidrotic Ectodermal Dysplasia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 28, 2012Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment27

Start dateFeb 2011

Last updatedJun 28, 2012

Condition

Hypohidrotic Ectodermal Dysplasia

Locations shown

University of California

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 28, 2012Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions